Dimerix Limited is a clinical stage biotechnology company that is listed on the Australian Stock Exchange (ASX:DXB)
Our vision is to positively improve human health by creating safe and effective new treatments for patients with unmet medical needs
Recent news and media
Dimerix CEO Kathy Harrison is pleased to be speaking alongside a great collection of other biotech companies at the Western Australian [...]
Dimerix has announced a proposed consolidation of DXB shares. Full details of the notification are available here.